Insurers forcing surgeons to use specific bone grafting products - Mark Copeland on BoneChan #38
11 Aug 2024 · 1 min

0:52
Mark Copeland explains how insurers and hospitals force surgeons to use specific bone graft products based on reimbursement, not clinical outcomes. Cell-based demineralized bone matrix products are being abandoned because insurers won't pay for them in certain cases, pushing surgeons back to traditional options. Hospital administrators effectively become salespeople, steering doctors through financial pressure rather than evidence.










